Calcutta High Court issues IP Division Rules
The Calcutta High Court recently adopted the much-awaited Intellectual Property Rights Division Rules, 2023 (Calcutta IPD Rules), making it the third High Court in India, after Delhi and Madras, to implement specialized regulations for IP matters. While the Calcutta...
AstraZeneca challenges Axelpharm’s cancer drug patent
AstraZeneca is a world-renowned pharmaceutical company. It owns many patents in Russia and takes steps to protect them against encroachers. Its medicines are exempt from sanctions because they are mainly used for the life-preserving treatment of cancer. Axelpharm, a...
The dark side of fake goods: consumers put health, safety, and the economy at risk while fuelling organized crime
Organized crime groups take advantage of worldwide demand for low-priced goods, misleading consumers into purchasing fake goods Approximately 86 million fake items were seized in the EU in 2022, with an estimated value exceeding €2 billion Counterfeit goods represent...
USPTO issues final rule on Director Review of PTAB decisions
On October 1, 2024, the USPTO published a new final rule, Rules Governing Director Review of Patent Trial and Appeal Board (PTAB) Decisions. 89 Fed. Reg. 79,744 (October 1, 2024). The final rule codifies many aspects of the PTAB’s revised interim Director Review...
UK IPO campaign highlights dangers of counterfeit vehicle parts
The campaign focuses on the serious risks these goods pose, warning that ‘Fake Always Breaks’ The UK Intellectual Property Office (UKIPO) has launched a new national awareness campaign warning of the dangers of buying counterfeit vehicle parts The ‘Fake Always...
Divisional applications in Russia: does the story continue?
On June 4, 2024, the Russian Supreme Court issued a decision that finalized the litigation between KRKA, d.d., Novo mesto (Slovenia), and AstraZeneca AB (Sweden) on invention patent 2643764. About half a year earlier, on January 2, 2024, the Italian Supreme Court...
Open Invention Network expands patent protection for largest cross-license in history
Open Invention Network (OIN) oversees the largest patent cross-license in history, with more than 3,800 participants. The cross-license covers basic software componentry across a spectrum of vertical industries that include security, networking, cloud computing,...
A novel twin-litigation strategy: how France can help sidestep the jurisdiction wrangling issue
Patent owners and implementers have struggled to litigate global FRAND rates when negotiations do not lead to a license. FRAND, the concept that a patent owner who participated in creating technical standards used by all companies in an industry should license their...
Stuff You Should Know About IP podcast: new episode out now!
CTC Legal Media is very excited to announce that, after a long hiatus, the Stuff You Should Know About IP podcast is back with a brand new episode! Hosted by Ray Guarnieri and Thomas J. Colson, episode 50 focuses on eight intellectual property challenges startups must...
USPTO on trial: patent office sued for patent infringement
The US Patent and Trademark Office (USPTO) has been sued for allegedly infringing on six patents it previously granted. The patents involved are two-factor authentication systems belonging to two individual inventors and are now being contested by Factor2 Multimedia....
Pfizer triumphs over AstraZeneca in cancer drug patent dispute
In a landmark ruling, the US District Court for the District of Delaware has ordered AstraZeneca to pay Pfizer $107.5 million in damages for infringing on patents related to the lung cancer drug 'Tagrisso.' This case marks a significant victory for Pfizer in the...
Tencent demonstrates longstanding dedication to protecting and enhancing the value of IP at INTA’s 2024 Annual Meeting
ATLANTA, GEORGIA – May 22, 2024 – At this week’s International Trademark Association (INTA) 2024 Annual Meeting, INTA partner and Meeting sponsor Tencent joined thousands of attendees in celebrating the essential role of IP in creativity, commerce, and innovation. The...
‘Squeeze argument’ in patent infringement: tamper-evident closure case
A recent judgment on 8 May 2024, by the Hon'ble High Court of Delhi, in Guala Closures SPA v. AGI Greenpac Limited sheds light on the strategic maneuver known as the 'squeeze argument' and its profound significance in patent infringement cases. This case underscores...
ERS Genomics and IRBM sign CRISPR/Cas9 license agreement
The license agreement provides IRBM access to CRISPR gene editing technology to be applied across its drug discovery services offering. Dublin, Ireland, and Rome, Italy, 20 May 2024 — ERS Genomics Limited (‘ERS’), the CRISPR licensing Company, and IRBM, a leader in...
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.